Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications (Q42997932)

12 November 2017

Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications (English)

1 reference

12 November 2017

1 reference

Chuan-Mo Lee

1

1 reference

12 November 2017

Sheng-Nan Lu

2

1 reference

12 November 2017

Chao-Hung Hung

3

1 reference

12 November 2017

Wei-Chih Tung

4

1 reference

12 November 2017

Jing-Houng Wang

5

1 reference

12 November 2017

Hung-Da Tung

6

1 reference

12 November 2017

Chien-Hung Chen

7

1 reference

12 November 2017

Tsung-Hui Hu

8

1 reference

12 November 2017

Chi-Sin Changchien

9

1 reference

12 November 2017

Wei-Jen Chen

10

1 reference

12 November 2017

language of work or name

1 reference

26 January 2006

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

12 November 2017

1 reference

12 November 2017

100

1 reference

12 November 2017

8

1 reference

12 November 2017

767-774

1 reference

Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Correlation between virus genotype and chronicity rate in acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Genotypes of hepatitis C virus in chronic liver disease in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

HCV genotyping by three methods: analysis of discordant results based on sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Genotyping of hepatitis C virus-comparison of three assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Clinical relevance of hepatitis C virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Genotype distribution of hepatitis C virus infection in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Hepatitis C virus genotypes and development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Genotypes of hepatitis C virus in Taiwan and the progression of liver disease

21 January 2018

2 references

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

21 January 2018

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Natural history of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.10.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2005.10.008

1 reference

12 November 2017

1 reference